Headquartered in Hong Kong, Hua Han specializes in traditional antiaging and antitumor Chinese drugs for women, which it sells under the Yeosure brand.

FORBES: Magazine Article

Hong Kong-listed Hua Han shares sell for ten times their consensus 2006 earnings forecast and have an estimated multiple of just eight for 2007.

FORBES: Correction Appended

"Her case has thrown existing reform proposals into relief and it has also put into relief the trend of the public having a greater acceptance of removing nonviolent crimes from capital punishment, " said Joshua Rosenzweig, Hong Kong-based senior research manager for the Dui Hua Foundation.

WSJ: China Rejects Millionaire's Death Sentence